Burlingame, CA, April 21, 2025 (GLOBE NEWSWIRE) — Coherent Market Insights published a report, titled, the global meningococcal vaccines market size is estimated to grow from US$ 4.53 Billion in 2025 and is forecast to reach a value of US$ 9.05 Billion by 2032 at a CAGR of 10.4% between 2025 and 2032.
Request Sample Pages: https://www.coherentmarketinsights.com/insight/request-sample/3864
Global Meningococcal Vaccines Market Key Takeaways
• The global meningococcal vaccines market size is anticipated to grow nearly 2X, expanding from USD 4.53 Bn in 2025 to USD 9.05 Bn by 2032, recording a CAGR of 10.4% throughout the forecast period.
• Based on type, conjugate vaccines segment is expected to account for half of the revenue share in the global meningococcal vaccines market by 2025. This is due to advantages of conjugate vaccines, including long-lasting immunity and high avidity.
• In terms of sales channel, public segment will likely account for a dominant 60.1% of the global meningococcal vaccines market share in 2025.
• By age group, children and adults (2 years & above) segment is set to dominate the industry. Coherent Market Insights’ new meningococcal vaccines market research projects the target segment to account for around USD 3.193 Bn in 2025.
• North America will likely retain its dominance during the forecast period, owing to strong presence of meningococcal vaccine manufacturers and continuous advancements in vaccine technologies. As per Coherent Market Insights’ latest meningococcal vaccines market analysis, North America is poised to account for around 2/5th of the global market share.
• Asia Pacific is anticipated to emerge as a highly remunerative pocket for companies. This is attributable to increasing prevalence of meningococcal disease, growing health consciousness, and increasing healthcare investment across nations like India and China.
Meningococcal Vaccines Market Report Coverage
| Report Coverage | Details |
| Market Revenue in 2025 | $4.53 billion |
| Estimated Value by 2032 | $9.05 billion |
| Growth Rate | Poised to grow at a CAGR of 10.4% |